BDR Pharmaceuticals introduces prostate cancer treatment drug in oral solution form – ET HealthWorld | Pharma
![BDR Pharmaceuticals introduces prostate cancer treatment drug in oral solution form – ET HealthWorld | Pharma BDR Pharmaceuticals introduces prostate cancer treatment drug in oral solution form – ET HealthWorld | Pharma](https://etimg.etb2bimg.com/thumb/msid-106519714,imgsize-13300,width-1200,height=765,overlay-ethealth/pharma/pharma-industry/bdr-pharmaceuticals-introduces-prostate-cancer-treatment-drug-in-oral-solution-form.jpg)
New Delhi: BDR Pharmaceuticals on Tuesday said it has introduced Enzalutamide oral solution for treatment of prostate cancer, claiming to ...
Read more
US FDA approvals bounce back in 2023, sparking hopes of a biotech recovery – ET HealthWorld | Pharma
![US FDA approvals bounce back in 2023, sparking hopes of a biotech recovery – ET HealthWorld | Pharma US FDA approvals bounce back in 2023, sparking hopes of a biotech recovery – ET HealthWorld | Pharma](https://etimg.etb2bimg.com/thumb/msid-106515457,imgsize-15034,width-1200,height=765,overlay-ethealth/pharma/pharma-industry/us-fda-approvals-bounce-back-in-2023-sparking-hopes-of-a-biotech-recovery.jpg)
Bengaluru: The US Food and Drug Administration approved nearly 50 per cent more novel drugs in 2023 than in 2022, ...
Read more
Glenmark launches biosimilar of anti-diabetic drug Liraglutide in India – ET HealthWorld | Pharma
![Glenmark launches biosimilar of anti-diabetic drug Liraglutide in India – ET HealthWorld | Pharma Glenmark launches biosimilar of anti-diabetic drug Liraglutide in India – ET HealthWorld | Pharma](https://etimg.etb2bimg.com/thumb/msid-106509034,imgsize-12156,width-1200,height=765,overlay-ethealth/pharma/pharma-industry/glenmark-launches-biosimilar-of-anti-diabetic-drug-liraglutide-in-india.jpg)
Mumbai: Glenmark Pharmaceuticals Ltd has launched a biosimilar of the anti-diabetic drug Liraglutide for the first time in India, The ...
Read more
Novartis signs gene therapy deal with Voyager for $100 mln upfront – ET HealthWorld | Pharma
![Novartis signs gene therapy deal with Voyager for 0 mln upfront – ET HealthWorld | Pharma Novartis signs gene therapy deal with Voyager for 0 mln upfront – ET HealthWorld | Pharma](https://etimg.etb2bimg.com/thumb/msid-106504659,imgsize-12854,width-1200,height=765,overlay-ethealth/pharma/pharma-industry/novartis-signs-gene-therapy-deal-with-voyager-for-100-mln-upfront.jpg)
Bangalore: Voyager Therapeutics said on Tuesday Swiss-based drugmaker novartis would pay $100 million upfront as part of a licensing deal ...
Read more
Novartis signs gene therapy deal with Voyager for $100 mln upfront – ET HealthWorld | Pharma
![Novartis signs gene therapy deal with Voyager for 0 mln upfront – ET HealthWorld | Pharma Novartis signs gene therapy deal with Voyager for 0 mln upfront – ET HealthWorld | Pharma](https://etimg.etb2bimg.com/thumb/msid-106504659,imgsize-12854,width-1200,height=765,overlay-ethealth/pharma/pharma-industry/novartis-signs-gene-therapy-deal-with-voyager-for-100-mln-upfront.jpg)
Bangalore: Voyager Therapeutics said on Tuesday Swiss-based drugmaker novartis would pay $100 million upfront as part of a licensing deal ...
Read more
IIL to invest Rs 700 crore on it greenfield veterinary vaccine facility in Hyderabad’s Genome Valley – ET HealthWorld | Pharma
![IIL to invest Rs 700 crore on it greenfield veterinary vaccine facility in Hyderabad’s Genome Valley – ET HealthWorld | Pharma IIL to invest Rs 700 crore on it greenfield veterinary vaccine facility in Hyderabad’s Genome Valley – ET HealthWorld | Pharma](https://etimg.etb2bimg.com/thumb/msid-106353476,imgsize-1546360,width-1200,height=765,overlay-ethealth/pharma/pharma-industry/iil-to-invest-rs-700-crore-on-it-greenfield-veterinary-vaccine-facility-in-hyderabads-genome-valley.jpg)
Hyderabad: Indian Immunologicals Limited ,IIL) on Thursday announced that it has started construction of its new greenfield veterinary vaccine facility ...
Read more
US FDA places clinical hold on Iovance’s lung cancer treatment trial – ET HealthWorld | Pharma
![US FDA places clinical hold on Iovance’s lung cancer treatment trial – ET HealthWorld | Pharma US FDA places clinical hold on Iovance’s lung cancer treatment trial – ET HealthWorld | Pharma](https://etimg.etb2bimg.com/thumb/msid-106353262,imgsize-22840,width-1200,height=765,overlay-ethealth/pharma/pharma-industry/us-fda-places-clinical-hold-on-iovances-lung-cancer-treatment-trial.jpg)
New Delhi: The US Food and Drug Administration has placed a clinical hold on iovance Biotherapeutics’ lung cancer therapy trial ...
Read more
Gennova sees uptick in its Omicron-specific COVID booster – ET HealthWorld | Pharma
![Gennova sees uptick in its Omicron-specific COVID booster – ET HealthWorld | Pharma Gennova sees uptick in its Omicron-specific COVID booster – ET HealthWorld | Pharma](https://etimg.etb2bimg.com/thumb/msid-106351680,imgsize-19308,width-1200,height=765,overlay-ethealth/pharma/pharma-industry/gennova-sees-uptick-in-its-omicron-specific-covid-booster.jpg)
New Delhi: Pune-based biotech firm Gennova Biopharmaceuticals has witnessed a demand uptick for its Omicron-specific Covid-19 vaccine, with the recent ...
Read more
Notice to med stores on sale of anti-cold drugs for kids – ET HealthWorld | Pharma
![Notice to med stores on sale of anti-cold drugs for kids – ET HealthWorld | Pharma Notice to med stores on sale of anti-cold drugs for kids – ET HealthWorld | Pharma](https://etimg.etb2bimg.com/thumb/msid-106350749,imgsize-12896,width-1200,height=765,overlay-ethealth/pharma/pharma-industry/notice-to-med-stores-on-sale-of-anti-cold-drugs-for-kids.jpg)
Kolkata : Doctors in the city have cautioned parents not to buy. fixed drug combinations ,F.D.C.) over the counter after ...
Read more